Articles

Monkeypox infection is an emerging viral zoonotic infection caused by a DNA virus named Monkeypox virus. Humans acquired the infection in several ways, such as through contact with infected animals and infected humans and sexual transmission. The disease is characterized by fever, headache, fatigue, the distribution of pain through the body, skin rash, and enlargement of lymph nodes. In 2024, the resurgence of the Monkeypox virus will become a significant public health concern, marked by increased incidence and geographical spread. This article provides an overview of the current state of the outbreak, examining contributing factors such as changes in human behavior, global travel patterns, and gaps in vaccination coverage. We analyze recent epidemiological data, including transmission dynamics and affected populations, to assess the impact on healthcare systems. The response strategies implemented so far, including enhanced surveillance, vaccination campaigns, and public health interventions, are evaluated for their effectiveness. The findings underscore the need for continued global cooperation, investment in research, and robust health infrastructure to manage and mitigate the ongoing risk of Monkeypox and similar infectious diseases. In the current article review, the World Health Organization (WHO) declared the waves and outbreak of MPXV to be a public health emergency globally. Collaborative efforts between governments, healthcare providers, and international organizations will be essential in managing this evolving threat and safeguarding public health.